{NAME}, here’s what the ELEVIDYS approval means

This goes far beyond treating one disease [This goes far beyond treating one disease]( [MDA - Muscular Dystrophy Association]( [Donate Now]( [BREAKING NEWS]( Dear {NAME}, I’m deeply excited by the FDA’s approval of ELEVIDYS to treat Duchenne muscular dystrophy (DMD). We finally have a gene therapy to treat this fatal disease. But I’m also excited by what it means for other families in the neuromuscular disease community—and even beyond. The approval opened an unprecedented era of treatment and understanding of neuromuscular diseases. And what researchers have learned in creating ELEVIDYS could be applied to other diseases, changing millions of lives. Hope is becoming reality—because of you. [Will you give today to help build on this incredible success?]( Your partner in breakthroughs, [Jeremy Signature] Jeremy Kraut-Ordover, CFRE Chief Development Officer [I'LL GIVE NOW]( [Forward this email to a friend!]( [MDA - Muscular Dystrophy Association]( [Donate Now]( [Facebook]( [Twitter]( [YouTube]( [Instagram]( [LinkedIn]( © 2023 Muscular Dystrophy Association All rights reserved. Muscular Dystrophy Association 161 N. Clark, Suite 3550 Chicago, IL 60601, US | 1-800-572-1717 [Unsubscribe]( | [State Fundraising Notice]( The Muscular Dystrophy Association (MDA) is a qualified 501(c)(3) tax-exempt organization. [View Online]( | [Privacy Policy](